Retatrutide is a synthetic triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, with a modified amino acid sequence. It is provided in lyophilized powder form with high purity for metabolic research.
Disclaimer: For research purposes only. Not intended for human or animal consumption, medical diagnosis, treatment, or any therapeutic application. All sales are subject to federal regulations; buyer must ensure proper handling and legal compliance.
Reviews
There are no reviews yet.